BBVA
MRKR icon

Banco Bilbao Vizcaya Argentaria’s Marker Therapeutics MRKR Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,704
Closed -$118K – 730
2020
Q2 		$118K Hold
5,704
– – ﹤0.01% 734
2020
Q1 		$108K Buy
+5,704
New +$145K ﹤0.01% 650

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's MRKR Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Marker Therapeutics (MRKR) in Q3 2020, closing a stake of 5,704 shares — an estimated $118K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in MRKR in Q1 2020 and held it in 2 quarters. The position peaked at $118K in Q2 2020. 58 funds tracked by Wall St. Rank hold MRKR as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Marker Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 5,704 Marker Therapeutics shares in Q3 2020, an estimated $118K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Marker Therapeutics in Q1 2020 and held it in 2 quarters.
  • Banco Bilbao Vizcaya Argentaria's Marker Therapeutics position peaked at $118K in Q2 2020.
  • 58 funds tracked by Wall St. Rank held Marker Therapeutics as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.